These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1563131)

  • 41. Diltiazem and propranolol in combination: hemodynamic effects following acute intravenous administration.
    Oesterle SN; Alderman EL; Beier-Scott L; Baim DS; Rothman MT; Schroeder JS
    Am Heart J; 1986 Mar; 111(3):489-97. PubMed ID: 3953357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diltiazem, verapamil, and quinidine in patients with chronic atrial fibrillation.
    Ochs HR; Anda L; Eichelbaum M; Greenblatt DJ
    J Clin Pharmacol; 1985 Apr; 25(3):204-9. PubMed ID: 3889076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of diltiazem or propranolol during exercise training of hypertensive men.
    Stewart KJ; Effron MB; Valenti SA; Kelemen MH
    Med Sci Sports Exerc; 1990 Apr; 22(2):171-7. PubMed ID: 2355813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ECG of the Month. Atrial fibrillation.
    Jung S; Griffiths LG
    J Am Vet Med Assoc; 2011 May; 238(10):1258-60. PubMed ID: 21568768
    [No Abstract]   [Full Text] [Related]  

  • 45. [Efficacy of diltiazem in blood pressure increase caused by exertion].
    Alitto F; Loison M; Neri G; Santostasi G; Corso S; Sandri R; Maragno I
    Minerva Cardioangiol; 1989 Mar; 37(3):119-24. PubMed ID: 2747939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative effects of propranolol and diltiazem on systolic and diastolic left ventricular function in essential hypertension.
    Ramanathan KB; Ratts TE; Griffin B; Sullivan JM
    J Hum Hypertens; 1990 Dec; 4(6):677-86. PubMed ID: 2096210
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diltiazem and exercise performance in patients with chronic atrial fibrillation.
    Atwood JE; Myers JN; Sullivan MJ; Forbes SM; Pewen WF; Froelicher VF
    Chest; 1988 Jan; 93(1):20-5. PubMed ID: 3335153
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Control of rate versus rhythm in rheumatic atrial fibrillation: a randomized study.
    Vora A; Karnad D; Goyal V; Naik A; Gupta A; Lokhandwala Y; Kulkarni H; Singh B
    Indian Heart J; 2004; 56(2):110-6. PubMed ID: 15377131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors affecting the clinical response to treatment with digoxin and two calcium antagonists in patients with atrial fibrillation.
    Lewis RV; McDevitt DG
    Br J Clin Pharmacol; 1988 May; 25(5):603-6. PubMed ID: 3044426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The evidence regarding the drugs used for ventricular rate control.
    Segal JB; McNamara RL; Miller MR; Kim N; Goodman SN; Powe NR; Robinson K; Yu D; Bass EB
    J Fam Pract; 2000 Jan; 49(1):47-59. PubMed ID: 10678340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Should chronic atrial fibrillation be treated with digoxin?].
    Garre K
    Ugeskr Laeger; 1990 Aug; 152(35):2475-8. PubMed ID: 1976285
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation.
    Ang EL; Chan WL; Cleland JG; Moore D; Krikler SJ; Alexander ND; Oakley CM
    Br Heart J; 1990 Oct; 64(4):256-60. PubMed ID: 1977430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diltiazem-induced left ventricular mass regression in hypertensive patients.
    Weiss RJ; Bent B
    J Clin Hypertens; 1987 Jun; 3(2):135-43. PubMed ID: 2956372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Troponin I levels in permanent atrial fibrillation-impact of rate control and exercise testing.
    Horjen AW; Ulimoen SR; Enger S; Norseth J; Seljeflot I; Arnesen H; Tveit A
    BMC Cardiovasc Disord; 2016 May; 16():79. PubMed ID: 27142292
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Verapamil improves exercise capacity in chronic atrial fibrillation: double-blind crossover study.
    Lang R; Klein HO; Di Segni E; Gefen J; Sareli P; Libhaber C; David D; Weiss E; Guerrero J; Kaplinsky E
    Am Heart J; 1983 May; 105(5):820-5. PubMed ID: 6846125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rate-control drugs affect variability and irregularity measures of RR intervals in patients with permanent atrial fibrillation.
    Corino VD; Ulimoen SR; Enger S; Mainardi LT; Tveit A; Platonov PG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):137-41. PubMed ID: 25367150
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Xamoterol improves the control of chronic atrial fibrillation in elderly patients.
    Lawson-Matthew PJ; McLean KA; Dent M; Austin CA; Channer KS
    Age Ageing; 1995 Jul; 24(4):321-5. PubMed ID: 7484490
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of rapid ventricular rate in acute atrial fibrillation.
    Shettigar UR
    Int J Clin Pharmacol Ther; 1994 May; 32(5):240-5. PubMed ID: 7921518
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study.
    Kochiadakis GE; Kanoupakis EM; Kalebubas MD; Igoumenidis NE; Vardakis KE; Mavrakis HE; Vardas PE
    Europace; 2001 Jan; 3(1):73-9. PubMed ID: 11271956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calcium chloride before i.v. diltiazem in the management of atrial fibrillation.
    Kolkebeck T; Abbrescia K; Pfaff J; Glynn T; Ward JA
    J Emerg Med; 2004 May; 26(4):395-400. PubMed ID: 15093843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.